The specific value of upgrading to left bundle branch area pacing in patients with pacing-induced cardiomyopathy or non-pacing-induced cardiomyopathy related upgrade status: A retrospective study.
cardiac function
cardiac pacing
heart failure
left bundle branch area pacing
pacing-induced cardiomyopathy
Journal
Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
17
04
2023
received:
22
02
2023
accepted:
02
05
2023
medline:
14
7
2023
pubmed:
29
5
2023
entrez:
29
5
2023
Statut:
ppublish
Résumé
Left bundle branch area pacing (LBBaP) upgrade can improve cardiac function and clinical outcomes in patients with pacing-induced cardiomyopathy (PICM), but the specific value of LBBaP upgrade, especially compared with the cardiac function level before right ventricular pacing (RVP) in patients with PICM and non-pacing-induced cardiomyopathy-related upgrade status (Non-PICMUS) is still unknown. This study retrospectively enrolled 70 patients with LBBaP upgrade (38 patients with PICM and 32 patients with Non-PICMUS). All upgrade patients experienced three stages: before RVP (Pre-RVP), before LBBaP upgrade (Pre-LBBaP), and after LBBaP upgrade (Post-LBBaP). QRS duration (QRSd), lead parameters, echocardiographic indicators, and clinical outcomes evaluation were recorded at multiple time points. At the follow-up of 12 months, for PICM patients, left ventricular ejection fraction (LVEF) significantly increased from 36.6% ± 7.2% to 51.3% ± 8.7% Post-LBBaP (p < .001), and left ventricular end-diastolic diameter (LVEDD) significantly decreased from 61.5 ± 6.4 mm to 55.2 ± 6.5 mm Post-LBBaP (p < .001), but they both failed to restore the level Pre-RVP (both p < .001). For PICM patients, New York Heart Association (NYHA) classification, the number of moderate-to-severe heart failure (NYHA III-IV), and diuretics using rate after the LBBaP upgrade also could not restore to the level Pre-RVP (all p < .001). At the follow-up of 12 months, Non-PICMUS patients after the LBBaP upgrade had no significant improvement in LVEF, LVEDD, and NYHA classification (all p > .05). LBBaP upgrade effectively improved the cardiac function and clinical outcomes in PICM patients, but its effectiveness seemed to be limited as the deteriorated cardiac function cannot be completely reversed. For Non-PICMUS patients, the cardiac function and clinical outcomes Post-LBBaP had no significant improvement.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
761-770Subventions
Organisme : National Natural Science Foundation of China
ID : 81800212
Organisme : National Natural Science Foundation of China
ID : 82070408
Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Dawkins JF, Hu YF, Valle J, et al. Antegrade conduction rescues right ventricular pacing-induced cardiomyopathy in complete heart block. J Am Coll Cardiol. 2019;73(13):1673-1687. doi:10.1016/j.jacc.2018.12.086
Khurshid S, Epstein AE, Verdino RJ, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy. Heart Rhythm. 2014;11(9):1619-1625. doi:10.1016/j.hrthm.2014.05.040
Kiehl EL, Makki T, Kumar R, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm. 2016;13(12):2272-2278. doi:10.1016/j.hrthm.2016.09.027
Yang YH, Wang KX, Ma PP, et al. His-purkinje system pacing upgrade improve the heart performances in patients suffering from pacing-induced cardiomyopathy with or without permanent atrial fibrillation. Int J Cardiol. 2021;335:47-51. doi:10.1016/j.ijcard.2021.04.012
Ye Y, Wu S, Su L, Sheng X, et al. Feasibility and outcomes of upgrading to left bundle branch pacing in patients with pacing-induced cardiomyopathy and infranodal atrioventricular block. Front Cardiovasc Med. 2021;8:674452. doi:10.3389/fcvm.2021.674452
Khurshid S, Obeng-Gyimah E, Supple GE, et al. Reversal of pacing-induced cardiomyopathy following cardiac resynchronization therapy. JACC Clin Electrophysiol. 2018;4(2):168-177. doi:10.1016/j.jacep.2017.10.002
Sieniewicz BJ, Gould J, Porter B, et al. Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions. Heart Fail Rev. 2019;24(1):41-54. doi:10.1007/s10741-018-9734-8
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. doi:10.1093/eurheartj/ehab368
Shan P, Su L, Zhou X, et al. Beneficial effects of upgrading to His bundle pacing in chronically paced patients with left ventricular ejection fraction <50. Heart Rhythm. 2018;15(3):405-412.
Huang W, Su L, Wu S, et al. A novel pacing strategy with low and stable output: pacing the left bundle branch immediately beyond the conduction block. Can J Cardiol. 2017;33(12):1736.e1-1736.e3. doi:10.1016/j.cjca.2017.09.013
Hua W, Fan X, Li X, et al. Comparison of left bundle branch and his bundle pacing in bradycardia patients. JACC Clinical electrophysiology. 2020;6(10):1291-1299. doi:10.1016/j.jacep.2020.05.008
Ponnusamy SS, Vijayaraman P. Left bundle branch block-induced cardiomyopathy: insights from left bundle branch pacing. JACC Clin Electrophysiol. 2021;7(9):1155-1165. doi:10.1016/j.jacep.2021.02.004
Zhuo W, Zhong X, Liu H, et al. Pacing characteristics of his bundle pacing vs. left bundle branch pacing: a systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:849143. doi:10.3389/fcvm.2022.849143
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (London, England). 2007;370(9596):1453-1457. doi:10.1016/S0140-6736(07)61602-X
Huang W, Chen X, Su L, Wu S, Xia X, Vijayaraman P. A beginner's guide to permanent left bundle branch pacing. Heart Rhythm. 2019;16(12):1791-1796. doi:10.1016/j.hrthm.2019.06.016
Burri H, Jastrzebski M, Cano Ó, et al. EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS). Europace. 2023;25(4):1208-1236. doi:10.1093/europace/euad043
Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for Performing a Comprehensive Transthoracic Echocardiographic Examination in Adults: recommendations from the American Society of Echocardiography. Am Soc Echocardiogr. 2019;32(1):1-64. doi:10.1016/j.echo.2018.06.004
Nielsen JC, Andersen HR, et al. Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing. Circulation. 1998;97(10):987-995. doi:10.1161/01.CIR.97.10.987
Tops LF, Schalij MJ, Bax JJ. The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. J Am Coll Cardiol. 2009;54(9):764-776. doi:10.1016/j.jacc.2009.06.006
Gardas R, Golba KS, Soral T, et al. The effects of his bundle pacing compared to classic resynchronization therapy in patients with pacing-induced cardiomyopathy. J Clin Med. 2022;11(19):5723. doi:10.3390/jcm11195723
Qian Z, Wang Y, Hou X, et al. Efficacy of upgrading to left bundle branch pacing in patients with heart failure after right ventricular pacing. Pacing Clin Electrophysiol: PACE. 2021;44(3):472-480. doi:10.1111/pace.14147
Rademakers LM, Bouwmeester S, Mast TP, Dekker L, Houthuizen P, Bracke FA. Feasibility, safety and outcomes of upgrading to left bundle branch pacing in patients with right ventricular pacing induced cardiomyopathy. Pacing Clin Electrophysiol: PACE. 2022;45(6):726-732. doi:10.1111/pace.14515
Vijayaraman P, Herweg B, Dandamudi G, et al. Outcomes of His-bundle pacing upgrade after long-term right ventricular pacing and/or pacing-induced cardiomyopathy: insights into disease progression. Heart Rhythm. 2019;16(10):1554-1561. doi:10.1016/j.hrthm.2019.03.026
Karpawich PP, Rabah R, Haas JE. Altered cardiac histology following apical right ventricular pacing in patients with congenital atrioventricular block. Pacing Clin Electrophysiol: PACE. 1999;22(9):1372-1377. doi:10.1111/j.1540-8159.1999.tb00631.x
Naqvi TZ, Chao CJ. Adverse effects of right ventricular pacing on cardiac function: prevalence, prevention and treatment with physiologic pacing. Trends Cardiovasc Med. 2021;33(2):109-122. doi:10.1016/j.tcm.2021.10.013
Chen Z, Sohal M, Sammut E, et al. Focal but not diffuse myocardial fibrosis burden quantification using cardiac magnetic resonance imaging predicts left ventricular reverse modeling following cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2016;27(2):203-209. doi:10.1111/jce.12855
Wang J, Gong X, Chen H, et al. Effect of cardiac resynchronization therapy on myocardial fibrosis and relevant cytokines in a canine model with experimental heart failure. J Cardiovasc Electrophysiol. 2017;28(4):438-445. doi:10.1111/jce.13171
Cho SW, Gwag HB, Hwang JK, et al. Clinical features, predictors, and long-term prognosis of pacing-induced cardiomyopathy. Eur J Heart Fail. 2019;21(5):643-651. doi:10.1002/ejhf.1427
Kim JH, Kang KW, Chin JY, Kim TS, Park JH, Choi YJ. Major determinant of the occurrence of pacing-induced cardiomyopathy in complete atrioventricular block: a multicentre, retrospective analysis over a 15-year period in South Korea. BMJ open. 2018;8(2):e019048. doi:10.1136/bmjopen-2017-019048
Zhang J, Zhang Y, Zhou X, et al. QRS duration shortening predicts left ventricular reverse remodelling in patients with dilated cardiomyopathy after cardiac resynchronization therapy. Acta Cardiol. 2015;70(3):307-313. doi:10.1080/AC.70.3.3080635
Coppola G, Ciaramitaro G, Stabile G, et al. Magnitude of QRS duration reduction after biventricular pacing identifies responders to cardiac resynchronization therapy. Int J Cardiol. 2016;221:450-455. doi:10.1016/j.ijcard.2016.06.203
Zhang H, Zhou YJ, Zeng YJ. Prognostic factors of pacing-induced cardiomyopathy. Chin Med J. 2020;133(13):1533-1539. doi:10.1097/CM9.0000000000000856
Chang PC, Wo HT, Chen TH, Wu D, Lin FC, Wang CC. Remote past left ventricular function before chronic right ventricular pacing predicts responses to cardiac resynchronization therapy upgrade. Pacing Clin Electrophysiol: PACE. 2014;37(4):454-463. doi:10.1111/pace.12291
Saunderson CED, Paton MF, Brown LAE, et al. Detrimental immediate- and medium-term clinical effects of right ventricular pacing in patients with myocardial fibrosis. Circ Cardiovasc Imaging. 2021;14(5):e012256. doi:10.1161/CIRCIMAGING.120.012256
Li Y, Yan L, Dai Y, et al. Feasibility and efficacy of left bundle branch area pacing in patients indicated for cardiac resynchronization therapy. Europace. 2020;22(Suppl_2):ii54-ii60. doi:10.1093/europace/euaa271
Zhang W, Huang J, Qi Y, et al. Cardiac resynchronization therapy by left bundle branch area pacing in patients with heart failure and left bundle branch block. Heart Rhythm. 2019;16(12):1783-1790. doi:10.1016/j.hrthm.2019.09.006
Su L, Wang S, Wu S, et al. Long-term safety and feasibility of left bundle branch pacing in a large single-center study. Circ Arrhythm Electrophysiol. 2021;14(2):e009261. doi:10.1161/CIRCEP.120.009261